摘要
自1954年Bartels等[1]报道了首例对比剂肾病(CIN)后,半个多世纪以来专家学者对其认识逐渐加深。CIN目前已是仅次于肾灌注不足和肾毒性药物引起的医院获得性急性肾损伤的第三大常见原因,占全部医院获得性急性肾损伤的11%[2]。
出处
《山东医药》
CAS
2012年第4期9-10,共2页
Shandong Medical Journal
参考文献11
-
1Bartels ED, Brun GC, Gammeltoft A, et al. Acute anuria following intravenous pyelography in a patient with myelomatosis [ J ]. Acta Med Scand, 1954,150 (4) :297-302.
-
2Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency [J]. Am J Kidney Dis, 2002,39(5) :930-936.
-
3McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy [ J ]. Am J Cardiol, 2006,98(6A) :5K-13K.
-
4Budano C, Levis M, D'Amico M, et al. Impact of contrast-induced acute kidney injury definition on clinical outcomes [ J ]. Am Heart J, 2011,161 (5) :963-971.
-
5de Bie MK, van Rees JB, Herzog CA, et al. How to reduce the incidence of contrast induced acute kidney injury after cardiac invasive procedures, a review and practical recommendations [ J]. Curt Med Res Opin, 2011,27(7) :1347-1357.
-
6Toprak O, Cirit M. Risk factors and therapy strategies for contrast- induced nephropathy [ J ]. Ren Fail, 2006,28 (5) :365-381.
-
7Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. NGAL ( neutrophil gelatinase-associated lipocalin) and cystatin C : are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creati- nine [J]. Int J Cardiol, 2008,127(2) :290-291.
-
8Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children [ J ]. Pediatr Nephrol, 2007,22 ( 12 ) :2089-2095.
-
9王冬松,李文华,韩飞,张延斌,徐通达,朱红,李东野.用ROC曲线评价NGAL对冠脉诊疗术后对比剂肾病的早期诊断价值[J].中华全科医学,2011,9(10):1503-1504. 被引量:4
-
10Caruso M, Balasus F, Incalcaterra E, et al. Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized [J]. Intern Med, 2011,50(9) :983-989.
二级参考文献10
-
1Mishra J, Morri K, Ma Q, et al. Amelioration of ischemic acute renal injuey by neutrophil gelatinase-associated lipocalin [ J ]. J Am Soc Nephrol,2004,15 ( 12 ) :3073-3082.
-
2Mori K, Lee HT, Rapoport D, et al. Endoeytic delivery of lipoealin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury [ J ]. J Clin Invest,2005,115 ( 3 ) :610-621.
-
3Ling W,Zhaohui N, Ben H, et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography [J]. Nephron Clin Pract, 2008,108 ( 3 ) : 176-181.
-
4Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. Neutrophil gelatinase associated lipocalin and renal function after percutaneous coronary interventions[J]. Am J Nephrol,2006 ,26 :287-292.
-
5Russel Hirsch, Catherine Dent, Holly Pfriem, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children [ J ]. Pediatric Nephrology ,2007,28:2089-2095.
-
6Mehran R. Contrast-induced nephropathy remains a serious complication of PCI[ J ]. J Interv Cardiol,2007,20 ( 3 ) :236-240.
-
7Stuart L. Goldstein. Pediatric acute kidney injury : it' s time for real progress[ J ]. Pediatr Nephrol,2006,21 ( 7 ) :891-895.
-
8Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associatedlipocalin as a novel early urinary biomarker for ischemic renal injury[J]. J Am Soc Nephrol,2003,14(10) :2534-2543.
-
9Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associatedlipocalin(NGAL) as a biomarker for acute renal injury after cardiac surgery[J]. Lancet,2005,365 ( 9466 ) : 1231-1238.
-
10Zappitelli M, Washburn KK, Arikan AA, et al. Urine neutrophil-gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children; a prosperctive cohort study [J]. Crit Care, 2007,11 (4) :R84.
共引文献3
-
1李军辉,宣昶有,简桂花,王锋,桂定坤,程东生,魏盟,汪年松.KIM-1检测冠脉造影后造影剂肾病的前瞻性研究[J].中华全科医学,2012,10(10):1513-1515. 被引量:11
-
2卢英,马建峰,张炳峰,李云飞.血清NGAL浓度对肾脏疾病诊断的意义[J].江苏医药,2013,39(24):3027-3028. 被引量:2
-
3赵宁,费晓,王鸣,高婵,谢祥成,徐群红.阿昔洛韦诱导的人肾小管上皮细胞NGAL、IL-18表达及其意义[J].中华全科医学,2014,12(12):1894-1896.
同被引文献13
-
1Krasuski RA, Beard BM, Geoghagan JD, et al. Optimal timing of hydra- tion to erase contrast-associated nephropathy:the OTHER CAN study[J]. J Invasive Cardiol, 2003,15 (12) : 699-702.
-
2Kagan A, Sheikh-Hamad D. Contrast-induced kidney injury:focus on modifiable risk factors and prophylactic strategies [ J ]. Clin Cardiol, 2010,33 (2) :62-66.
-
3Hardy J, Hambly B, Ko H, et al. Stimulation of mesangial cells by an- giotensin 1I and lipopolysaccharide crases expression of interleukin-18, but not IL-18 receptor [ J ]. Nephron Exp Nephrol, 2010,116 ( 4 ) : 63- 71.
-
4Odutayo A, Cherney D. Cystatin C and acute changes in glomerular fil- tration rate [ J]. Clin Nephro1,2012,78 ( 1 ) :64-75.
-
5Devarajan P. Biomarkers for the early detection of acute kidney injury [ J]. Curr Opifi Pediatr,2011,23 (2) : 194-200.
-
6Yue Du, Michael Zappitelli, Asad Mian, et al. Urinary biomarkers to detect acute kidney injury in the pediatric emergency center[ J]. Pedi- atric Nephrology,2011,26 (2) :267-274.
-
7Tehrani S, laing C,Yellon DM, et al. Contrast-induced acute kidney in- jury following PCI [ J ]. Eur J Clin Invest, 2013,43 ( 5 ) :483-490.
-
8Ling W,Zhao hui N,Ben H,et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography [ J ]. Nephron Clin Pratt ,2008,108 ( 3 ) : 176-181.
-
9Bulent Gul CB, gullulu M, Oral B, et al. Urinary 1L-18:a marker of contrast-induced nephropathy following percutaneous coronary inter- vention? [J]. Clin Bioehem.2008.41 (7-8 ):544-547.
-
10颜红兵,彭红玉.预防对比剂肾病的策略与进展[J].心血管病学进展,2009,30(5):765-768. 被引量:5
二级引证文献3
-
1方文宾,王文标,梁亚非,董扬,刘俊,俞北伟.冠心病患者冠状动脉侧支生成的影响因子分析[J].中国现代医生,2016,54(7):5-7. 被引量:2
-
2方文宾,王文标,梁亚非,董扬,刘俊,俞北伟,蔡哲钧.冠状动脉侧支循环形成的影响因素Logistic回归分析[J].中国现代医生,2016,54(10):26-29. 被引量:1
-
3李然,王德良.预测冠脉介入诊疗术后对比剂肾病中应用CMV和CrCl比值的重要价值[J].中国中西医结合肾病杂志,2017,18(10):882-884. 被引量:1
-
1李英,张艳.基层医院获得性急性肾损伤常见原因分析及防治体会[J].新疆医学,2012,42(5):83-85.
-
2廖昌兴,卢晓玲,曾宪凤.基层医院获得性急性肾损伤的临床特征[J].内科,2007,2(4):522-523. 被引量:2
-
3华伟.基层医院获得性急性肾损伤的临床分析[J].中国当代医药,2012,19(33):185-186. 被引量:1
-
4张文绵,肖文良.对比剂急性肾损害的研究进展[J].临床内科杂志,2013,30(4):287-288.
-
5金立军.老年人急性肾功能衰竭62例分析[J].中国误诊学杂志,2009,9(34):8483-8483. 被引量:1
-
6秦军建.维生素C防治对比剂肾病的观察分析[J].中华临床医师杂志(电子版),2013,7(3):179-180. 被引量:2
-
7韩正清,邱川,彭作荣,卿梅.219例急性肾功能衰竭的病因分析[J].现代医药卫生,2003,19(11):1417-1417.
-
8王振花,陈军.对比剂肾病病理生理机制的研究现状[J].医学综述,2014,20(2):265-268. 被引量:3
-
9赵守松.肝肾综合征的研究现状[J].实用肝脏病杂志,2006,9(1):58-61. 被引量:5
-
10余云生,沈振亚,于曙东,叶文学,焦鹏,黄浩岳,华菲.原位心脏移植术后急性肾功能衰竭的病因和治疗分析[J].苏州大学学报(医学版),2005,25(6):1099-1100. 被引量:1